Researchers identify how cancer cells can 'hijack' treatments designed to kill them

By Bridie Smith
Updated June 8 2015 - 10:08am, first published June 2 2015 - 11:33pm
Rosmary Goulding's ovarian cancer has returned twice, illustrating the problems clinicians have when treating cancer. Photo: Justin McManus
Rosmary Goulding's ovarian cancer has returned twice, illustrating the problems clinicians have when treating cancer. Photo: Justin McManus

Australian researchers have identified four key ways by which one of the most common type of ovarian cancers becomes resistant to chemotherapy, a breakthrough which will better match patients with the most effective treatment.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Batemans Bay news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.